{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:50:40Z","timestamp":1792626640363,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16601"],"award-info":[{"award-number":["20K16601"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.yebeh.2023.109225","type":"journal-article","created":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T11:06:33Z","timestamp":1682852793000},"page":"109225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Paradoxical effects of levetiracetam in people with epilepsy with rhythmic epileptiform discharges"],"prefix":"10.1016","volume":"143","author":[{"given":"Yoshiko","family":"Takebayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ohshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2023.109225_b0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2023.109225_b0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1528-1157.1998.tb01268.x","article-title":"Antiepileptic drugs as a cause of worsening seizures","volume":"39","author":"Perucca","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1056\/NEJM198510103131503","article-title":"Exacerbation of seizures in children by carbamazepine","volume":"313","author":"Snead","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2023.109225_b0020","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.33.11.1487","article-title":"Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children","volume":"33","author":"Shields","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109225_b0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1684\/j.1950-6945.2006.tb00159.x","article-title":"EEG and seizure exacerbation induced by carbamazepine in Panayiotopoulos syndrome","volume":"8","author":"Kikumoto","year":"2006","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2023.109225_b0030","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1528-1157.2000.tb00258.x","article-title":"Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine","volume":"41","author":"Osorio","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejpn.2011.05.007","article-title":"Aggravation of absence seizure related to levetiracetam","volume":"15","author":"Auvin","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2023.109225_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1684\/epd.2010.0305","article-title":"Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies","volume":"12","author":"Caraballo","year":"2010","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2023.109225_b0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/WNF.0000000000000304","article-title":"Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia","volume":"41","author":"Cvetkovska","year":"2018","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2023.109225_b0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNF.0000000000000171","article-title":"Paradoxical Effect of Levetiracetam in Newly Diagnosed Type II Focal Cortical Dysplasia","volume":"39","author":"Fois","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2023.109225_b0055","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.seizure.2012.08.008","article-title":"Levetiracetam-associated aggravation of myoclonic seizure in children","volume":"21","author":"Liu","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2023.109225_b0060","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12887-015-0330-y","article-title":"Paradoxical exacerbation of myoclonic-astatic seizures by levetiracetam in myoclonic astatic epilepsy","volume":"15","author":"Makke","year":"2015","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.yebeh.2023.109225_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1059131102001723","article-title":"A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy","volume":"12","author":"Nakken","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2023.109225_b0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/j.1528-1167.2008.01585.x","article-title":"The risk of paradoxical levetiracetam effect is increased in mentally retarded patients","volume":"49","author":"Szucs","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1528-1167.2007.01329_1.x","article-title":"Exacerbations of seizures by levetiracetam","volume":"49","author":"Thacker","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0080","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207784","article-title":"Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment","volume":"21","author":"Thakran","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2023.109225_b0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0035-1552617","article-title":"Focal Cortical Dysplasia","volume":"35","author":"Crino","year":"2015","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2023.109225_b0095","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.25322","article-title":"Scalp electroencephalographic biomarkers in epilepsy patients with focal cortical dysplasia","volume":"84","author":"Epitashvili","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2023.109225_b0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0013-4694(95)00266-9","article-title":"Usefulness of focal rhythmic discharges on scalp EEG of patients with focal cortical dysplasia and intractable epilepsy","volume":"98","author":"Gambardella","year":"1996","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2023.109225_b0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clinph.2019.08.028","article-title":"Repetitive miniature spikes - An underreported EEG pattern","volume":"131","author":"Unterberger","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"Pt 8","key":"10.1016\/j.yebeh.2023.109225_b0110","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/brain\/123.8.1733","article-title":"Stereoelectroencephalography in focal cortical dysplasia: a 3D approach to delineating the dysplastic cortex","volume":"123","author":"Chassoux","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2023.109225_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0125","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120100","article-title":"A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: Transient exacerbation or sustainable mitigation","volume":"434","author":"Neshige","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2023.109225_b0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0972-2327.128544","article-title":"Seizure frequency and severity: How really important are they for the quality of life of patients with refractory epilepsy","volume":"17","author":"Viteva","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.yebeh.2023.109225_b0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1108\/AMHID-10-2015-0050","article-title":"\u201cIntellectual developmental disorders\u201d: reflections on the international consensus document for redefining \u201cmental retardation-intellectual disability\u201d in ICD-11","volume":"10","author":"Bertelli","year":"2016","journal-title":"Adv Ment Health Intellect Disabil"},{"key":"10.1016\/j.yebeh.2023.109225_b0150","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1528-1167.2005.31405.x","article-title":"Photic- and pattern-induced seizures: a review for the Epilepsy Foundation of America Working Group","volume":"46","author":"Fisher","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0155","first-page":"753","article-title":"Optimizing the diagnosis of hippocampal sclerosis using MR imaging","volume":"14","author":"Jackson","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.yebeh.2023.109225_b0160","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1212\/WNL.40.12.1869","article-title":"Hippocampal sclerosis can be reliably detected by magnetic resonance imaging","volume":"40","author":"Jackson","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109225_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jnnp.65.5.656","article-title":"Regional changes in hippocampal T2 relaxation and volume: a quantitative magnetic resonance imaging study of hippocampal sclerosis","volume":"65","author":"Woermann","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2023.109225_b0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eplepsyres.2015.02.018","article-title":"Evaluation of amygdala pathology using (11)C-methionine positron emission tomography\/computed tomography in patients with temporal lobe epilepsy and amygdala enlargement","volume":"112","author":"Sone","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2023.109225_b0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Bl\u00fcmcke","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0180","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpainsymman.2018.07.012","article-title":"Levetiracetam","volume":"56","author":"Howard","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.yebeh.2023.109225_b0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cnp.2021.10.004","article-title":"Multifocal myoclonus as a presentation of levetiracetam toxicity","volume":"6","author":"Bou Nasif","year":"2021","journal-title":"Clin Neurophysiol Pract"},{"key":"10.1016\/j.yebeh.2023.109225_b0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.seizure.2009.01.006","article-title":"Levetiracetam accumulation in renal failure causing myoclonic encephalopathy with triphasic waves","volume":"18","author":"Vulliemoz","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2023.109225_b0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0013-4694(94)00335-I","article-title":"Cortical dysgenesis: serial EEG findings in children and adults","volume":"94","author":"Raymond","year":"1995","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2023.109225_b0200","doi-asserted-by":"crossref","first-page":"9861","DOI":"10.1073\/pnas.0308208101","article-title":"The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam","volume":"101","author":"Lynch","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.yebeh.2023.109225_b0205","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","article-title":"SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release","volume":"24","author":"Janz","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.yebeh.2023.109225_b0210","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.0b013e318228c110","article-title":"Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma","volume":"77","author":"de Groot","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2023.109225_b0215","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1528-1167.2008.01955.x","article-title":"Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers","volume":"50","author":"Toering","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuroscience.2012.06.058","article-title":"Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure","volume":"221","author":"Hanaya","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.yebeh.2023.109225_b0225","doi-asserted-by":"crossref","first-page":"15268","DOI":"10.1073\/pnas.96.26.15268","article-title":"Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)","volume":"96","author":"Crowder","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.yebeh.2023.109225_b0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/epi.12172","article-title":"Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoin","volume":"54","author":"Thomas","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2023.109225_b0235","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archneur.64.11.1595","article-title":"Epilepsy: accuracy of patient seizure counts","volume":"64","author":"Hoppe","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2023.109225_b0240","first-page":"77","article-title":"Risk factors of cognitive impairment in pediatric epilepsy patients with focal cortical dysplasia","volume":"41","author":"Kimura","year":"2019","journal-title":"BrainDev"},{"key":"10.1016\/j.yebeh.2023.109225_b0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2005.03.001","article-title":"Aggravation of epilepsy by antiepileptic drugs","volume":"33","author":"Sazgar","year":"2005","journal-title":"Pediatr Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505023001440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:07Z","timestamp":1761504607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505023001440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":49,"alternative-id":["S1525505023001440"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109225","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paradoxical effects of levetiracetam in people with epilepsy with rhythmic epileptiform discharges","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2023.109225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109225"}}